(Q37901231)

25 August 2017

1 reference

title

Plasma cell myeloma and related neoplasms (English)

1 reference

25 August 2017

4

Falko Fend

0 references

author name string

Robert B Lorsbach

series ordinal

1

1 reference

25 August 2017

Eric D Hsi

series ordinal

2

1 reference

25 August 2017

Ahmet Dogan

series ordinal

3

1 reference

American Journal of Clinical Pathology

25 August 2017

language of work or name

English

1 reference

inferred from

publication date

1 August 2011

1 reference

American Journal of Clinical Pathology

25 August 2017

published in

1 reference

25 August 2017

volume

136

1 reference

25 August 2017

issue

2

1 reference

25 August 2017

page(s)

168-182

1 reference

Genetic events in the pathogenesis of multiple myeloma

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1309%2FAJCPENJ68FFBRIYB

Molecular pathogenesis and a consequent classification of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPENJ68FFBRIYB

Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPENJ68FFBRIYB

Karyotypic abnormalities and clinical aspects of patients with multiple myeloma and related paraproteinemic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPENJ68FFBRIYB

Review of 1027 patients with newly diagnosed multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPENJ68FFBRIYB

Cyclin D1 positive multiple myeloma: predominance of the short, 3'UTR-deficient transcript is associated with high cyclin D1 mRNA levels in cases with t(11;14) translocation, but does not correlate with proliferation rate or genomic deletions

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPENJ68FFBRIYB

CD20 is associated with a small mature plasma cell morphology and t(11;14) in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPENJ68FFBRIYB

IgM myeloma: a rare entity characterized by a CD20-CD56-CD117- immunophenotype and the t(11;14).

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPENJ68FFBRIYB

Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPENJ68FFBRIYB

A single amino acid substitution in the variable region of the light chain specifically blocks immunoglobulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPENJ68FFBRIYB

A molecular basis for nonsecretory myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPENJ68FFBRIYB

Genetic aberrations and survival in plasma cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPENJ68FFBRIYB

Failure of red blood cell maturation in mice with defects in the high-density lipoprotein receptor SR-BI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPENJ68FFBRIYB

Plasma cell leukemia. Report on 17 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPENJ68FFBRIYB

Primary plasma cell leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPENJ68FFBRIYB

Primary plasma cell leukemia: report of 17 new cases treated with autologous or allogeneic stem-cell transplantation and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPENJ68FFBRIYB

A case of primary plasma cell leukemia with hairy-cell morphology and lambda-type Bence-Jones protein. Immunohistochemical and molecular analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPENJ68FFBRIYB

Frequent upregulation of MYC in plasma cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPENJ68FFBRIYB

Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPENJ68FFBRIYB

Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPENJ68FFBRIYB

Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPENJ68FFBRIYB

Primary extramedullary plasmacytoma: similarities with and differences from multiple myeloma revealed by interphase cytogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPENJ68FFBRIYB

Histologic classification and staging of multiple myeloma. A retrospective and prospective study of 674 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPENJ68FFBRIYB

Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPENJ68FFBRIYB

Influence of cytogenetics in patients with relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone: adverse effect of deletion 17p13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPENJ68FFBRIYB

Myeloma of the central nervous system: association with high-risk chromosomal abnormalities, plasmablastic morphology and extramedullary manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPENJ68FFBRIYB

Ras oncogene mutation in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPENJ68FFBRIYB

p53 gene deletion detected by fluorescence in situ hybridization is an adverse prognostic factor for patients with multiple myeloma following autologous stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPENJ68FFBRIYB

Loss of 1p and rearrangement of MYC are associated with progression of smouldering myeloma to myeloma: sequential analysis of a single case

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPENJ68FFBRIYB

International Myeloma Working Group molecular classification of multiple myeloma: spotlight review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPENJ68FFBRIYB

Chromosome translocations in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPENJ68FFBRIYB

Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPENJ68FFBRIYB

Plasmablastic lymphomas with MYC/IgH rearrangement: report of three cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPENJ68FFBRIYB

Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein-Barr virus-associated extramedullary plasmacytic neoplasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPENJ68FFBRIYB

High incidence of N and K-Ras activating mutations in multiple myeloma and primary plasma cell leukemia at diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPENJ68FFBRIYB

The (11;14)(q13;q32) Translocation in Multiple Myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPENJ68FFBRIYB

21 January 2018

Identifiers

DOI

10.1309/AJCPENJ68FFBRIYB

1 reference

25 August 2017

1 reference